Overcoming Chemoresistance via an AIEgen-Based Covalent Organic Framework

An Song1,2, Qing Wang1, Bo-Yu Liu3

  • 1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430079, China.

Nano Letters
|February 2, 2026
PubMed

Insights

A novel covalent organic framework (COF) nanomedicine effectively targets chemoresistant cancers by suppressing cancer stemness and immune suppression. This breakthrough nanomedicine shows significant potential for treating recurrent tumors and improving patient outcomes.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Cancer Research

Background:

  • Chemoresistance is a significant obstacle in cancer therapy, leading to treatment failure, tumor recurrence, and increased mortality.
  • Effective strategies are urgently needed to overcome chemoresistance and improve patient survival rates.

Purpose of the Study:

  • To develop and evaluate a novel covalent organic framework (COF) nanomedicine, 3N-DPQ-COF, for targeting and treating chemoresistant cancers.
  • To investigate the mechanisms by which 3N-DPQ-COF overcomes chemoresistance, including its effects on cancer stemness, the tumor microenvironment (TME), and immune activation.

Main Methods:

  • Synthesis and characterization of the AIEgen-based COF nanomedicine, 3N-DPQ-COF.
  • In vitro and in vivo evaluation of 3N-DPQ-COF in chemoresistant 4T1 and CT26 cancer models.
  • Assessment of 3N-DPQ-COF's impact on cancer stemness, TME composition (CD8+ T cells, myeloid-derived suppressor cells, erythroid progenitor cells), and pyroptosis induction (GSDME-dependent).

Main Results:

  • 3N-DPQ-COF demonstrated efficient accumulation in resistant tumor cells and suppressed cancer stemness, outperforming doxorubicin in 4T1 and CT26 models.
  • The nanomedicine promoted CD8+ T-cell infiltration, reduced immunosuppressive cells, and induced GSDME-dependent pyroptosis, effectively remodeling the TME.
  • Remarkably, 3N-DPQ-COF suppressed metastasis and recurrence in chemoresistant tumors, achieving over 90% tumor inhibition and cure rates exceeding 80% without checkpoint blockade.

Conclusions:

  • AIEgen-based COF nanomedicines, exemplified by 3N-DPQ-COF, offer a promising strategy for overcoming chemoresistance.
  • Concurrent modulation of tumor stemness, pyroptosis, and immune activation by 3N-DPQ-COF presents a potent approach for cancer treatment.
  • This study underscores the therapeutic potential of advanced nanomedicines in addressing critical challenges in oncology, including metastasis and recurrence.

Related Concept Videos

Covalent Bonds01:29

Covalent Bonds

Overview
162.3K
Covalent Bonds01:08

Covalent Bonds

Overview
When two atoms share electrons to complete their valence shells, they create a covalent bond. An atom's electronegativity—the force with which shared electrons are pulled towards an atom—determines how the electrons are shared. Molecules formed with covalent bonds can be either polar or nonpolar. Atoms with similar electronegativities form nonpolar covalent bonds; the electrons are shared equally. Atoms with different electronegativities share electrons unequally,...
11.0K
Network Covalent Solids02:18

Network Covalent Solids

Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

2.0K
Covalent Bonding and Lewis Structures02:46

Covalent Bonding and Lewis Structures

Compared to ionic bonds, which results from the transfer of electrons between metallic and nonmetallic atoms, covalent bonds result from the mutual attraction of atoms for a “shared” pair of electrons.
61.3K